a month ago
NBIX
AnalystsCarter GouldCarter Gould's Stock Forecasts
AnalystsCarter Gould
Analyst Ranking
Top 13%
#614 out of 4800 analysts
Average Return
+9.05%
Win Rate
50%58 out of 117
Risk vs Reward
Poor
Good
Carter Gould's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Skillsoft CorpSKIL | +455.96% | $5.45 | $30.30 | 2024-04-15 - 2025-01-24 | Strong Buy |
Reata Pharmaceuticals IncRETA | +334.02% | $38.27 | $166.10 | 2022-11-08 - 2023-08-01 | Strong Buy |
Travere Therapeutics IncTVTX | +125.67% | $9.00 | $20.31 | 2024-08-01 - 2025-01-24 | Strong Buy |
Travere Therapeutics IncTVTX | +93.76% | $7.85 | $15.21 | 2023-09-21 - 2024-09-20 | Strong Buy |
Eli Lilly & CoLLY | +92.48% | $405.81 | $781.10 | 2023-04-30 - 2024-04-30 | Strong Buy |
Carter Gould Analyst Color
Get additional color on Carter Gould's coverage of popular stocks
3 months ago
TVTX
3 months ago
LLY
4 months ago
ABBV
4 months ago
TVTX
6 months ago
REGN
6 months ago
NBIX
6 months ago
ABBV
6 months ago
LLY
6 months ago
PFE
6 months ago
REGN
7 months ago
GERN
10 months ago
ABBV
a year ago
LLY
a year ago
ABBV
a year ago
REGN
a year ago
NBIX
a year ago
LLY
a year ago
ABBV
a year ago
PFE
a year ago
PFE
a year ago
ABBV
a year ago
LLY
2 years ago
PFE
2 years ago
PFE
Carter Gould's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $165.00 | +10.94% | Maintains | a month ago |
Gilead Sciences IncGILD | 13 | Hold | $95.00 | +2.07% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 14 | Strong Buy | $1,065.00 | +57.59% | Maintains | 3 months ago |
Travere Therapeutics IncTVTX | 6 | Strong Buy | $20.00 | -1.53% | Maintains | 3 months ago |
Eli Lilly & CoLLY | 11 | Strong Buy | $975.00 | +24.14% | Maintains | 3 months ago |
Biogen IncBIIB | 21 | Hold | $180.00 | +23.12% | Maintains | 3 months ago |
Bristol Myers Squibb CoBMY | 14 | Strong Sell | $43.00 | -27.94% | Maintains | 4 months ago |
Merck & Co IncMRK | 10 | Strong Buy | $140.00 | +46.52% | Maintains | 4 months ago |
Amgen IncAMGN | 14 | Hold | $315.00 | +14.37% | Maintains | 4 months ago |
Abbvie IncABBV | 14 | Strong Buy | $212.00 | +24.49% | Maintains | 4 months ago |
Nuvalent IncNUVL | 1 | Strong Buy | $100.00 | +21.61% | Initiates Coverage On | 5 months ago |
Vor Biopharma IncVOR | 3 | Strong Buy | $3.00 | +104.78% | Maintains | 5 months ago |
Pfizer IncPFE | 13 | Hold | $32.00 | +22.65% | Maintains | 6 months ago |
Barinthus Biotherapeutics PLCBRNS | 1 | Strong Buy | $3.00 | +197.03% | Maintains | 7 months ago |
Geron CorpGERN | 1 | Strong Buy | $9.00 | +199.00% | Initiates Coverage On | 7 months ago |
Cytokinetics IncCYTK | 2 | Strong Buy | $95.00 | +87.19% | Maintains | 8 months ago |
Skillsoft CorpSKIL | 5 | Strong Buy | $20.00 | -33.99% | Maintains | 9 months ago |
Arcellx IncACLX | 4 | Strong Buy | $73.00 | +15.88% | Maintains | a year ago |
Allakos IncALLK | 4 | Strong Sell | $1.00 | N/A | Maintains | a year ago |
Reata Pharmaceuticals IncRETA | 7 | Hold | $172.00 | N/A | Downgrades | a year ago |
Alector IncALEC | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Gossamer Bio IncGOSS | 5 | Hold | $1.50 | N/A | Maintains | 2 years ago |
Molecular Templates IncMTEM | 3 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Applied Therapeutics IncAPLT | 4 | Hold | $2.25 | N/A | Maintains | 2 years ago |
Paycom Software IncPAYC | 1 | Hold | $380.00 | N/A | Maintains | 3 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $180.00 | N/A | Downgrades | 3 years ago |
Celgene CorpCELG | 3 | Hold | N/A | N/A | Downgrades | 6 years ago |
Incyte CorpINCY | 3 | Hold | $82.00 | N/A | Downgrades | 6 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Hold | $188.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.